Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience

• Main Authors: Lingzhi Qiu (Author), Le Ma (Author), Yifan Xie (Author), Jing Jin (Author), Yuting Pan (Author), Shumin Li (Author), Zhidan Fan (Author), Haiguo Yu (Author)
• Format: Book
• Published: BMC, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Systemic juvenile idiopathic arthritis (sJIA) is a severe form of juvenile arthritis that is characterized by chronic joint inflammation and systemic symptoms such as fever, rash, and organ involvement. Anti-IL-6 receptor monoclonal antibody tocilizumab is an effective treatment....